SCHEMBL6582601

SCHEMBL6582601

CN(C)C(=O)c1ccc2c(ccn2-c2ccc(F)cc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.53
MGLL Q99685 7/20 0.49
FAAH O00519 1/20 0.43
ROCK2 O75116 1/20 0.43
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
EPHX2 P34913 1/20 0.43
HPGDS O60760 1/20 0.41
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL122499 0.85 KCNH2 (0.57) KCNH2MGLLFAAHROCK2PIM1
SCHEMBL121755 0.83 MGLL (0.56) KCNH2MGLLFAAHROCK2PIM1
SCHEMBL149014 0.81 KDM4E (0.54) KCNH2MGLLEPHX2KDM4EALDH1A1
SCHEMBL6583340 0.81 KCNH2 (0.53) KCNH2MGLLFAAHROCK2PIM1
SCHEMBL28942962 0.77 KCNH2 (0.49) KCNH2MGLLFAAHROCK2PIM1
SCHEMBL30365056 0.77 KCNH2 (0.49) KCNH2MGLLFAAHROCK2PIM1
SCHEMBL20898076 0.76 KDM4E (0.49) KCNH2MGLLFAAHEPHX2KDM4E
SCHEMBL3431894 0.75 TUBB4A (0.52) ALDH1A1HPGDSMN1; SMN2MAOB
SCHEMBL5735272 0.73 KCNH2 (0.60) KCNH2MGLLFAAHEPHX2KDM4E
SCHEMBL9463558 0.73 KCNH2 (0.65) KCNH2MGLLEPHX2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6833376-B2 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal H. LUNDBECK A/S (DK) 2004-12-21 US disclosed
EP-1214312-B1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES LUNDBECK & CO AS H (DK) 2004-04-14 EP disclosed
US-20020169169-A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles H. LUNDBECK A/S (DK) 2002-11-14 US disclosed
EP-1214312-A1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 2002-06-19 EP disclosed
WO-2001021614-A1 5-AMINOALKYL AND 5-AMINOCARBONYL SUBSTITUTED INDOLES H. LUNDBECK A/S (DK) 2001-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169169-A1 5-aminoalkyl and 5-aminocarbonyl substituted indoles ADRB1, ADRA2C, ADRB2 KCNH2 79/4885MGLL 2216/4885FAAH 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.